[#item_full_content]This latest move from Larry Fink’s firm aims to further capitalize on the boom in stablecoin…
Month: October 2025
Doron Therapeutics Announces First Patients Dosed in Phase 3 Study of MOTYS (PTP-001) for the Treatment of Osteoarthritis of the Knee
[#item_full_content]CHAPEL HILL, N.C.–(BUSINESS WIRE)– #AlessandraPavesio–The Phase 3 study is a global trial to evaluate improvements in…
[#item_full_content]
[#item_full_content]
[#item_full_content]
[#item_full_content]
[#item_full_content]
[#item_full_content]
[#item_full_content]
[#item_full_content]
[#item_full_content]
[#item_full_content]
[#item_full_content]
[#item_full_content]
[#item_full_content]
[#item_full_content]
[#item_full_content]
[#item_full_content]